[19] DFG German Science Foundation. Analyses of Hazardous Substances in Biological Materials, Volumes 1-4, J. Angerer, K. H. Schaller, VCH Verlagsgesellschaft mbH, Weinheim (1985-1994).
[20] Methods for Biological Monitoring. A Manual for Assessing Human Exposure to Hazardous Substances, T. J. Kneip, J. V. Crable, American Public Health Association, Washington, D. C. (1988).
[21] Baselt, R. C. Biological Monitoring Methods for industrial Chemicals, Biomedical Publications, Davis (1980).
[22] Quality Assurance Considerations for Biological Monitoring, Chapter 12. In "Quality Assurance Manual for Industrial Hygiene Chemistry," AIHA Laboratory Analysis Committee. American Industrial Hygiene Association, Fairfax, pp. 77-89 (1995).
[23] Health & Safety Executive, United Kingdom. Biological Monitoring for Chemical Exposures in the Workplace. Guidance Note EH56 from Environmental hygiene Series HMSO, London (1992) in World Health Organization. Guidelines on Biological Monitoring of Chemical Exposure at the Workplace, Volumes 1 & 2, WHO, Geneva (in press).
[24] Alessio, L., V. Foa. Lead, Human Biological Monitoring of Industrial Chemical Series, L. Alessio, A. Berlin, R. Roi, M. Boni, Eds., Commission of the European Communities, Luxembourg (1983).
[25] Biagini, R. E., S. L. Klincewicz, G. M. Henningsen, B. MacKenzie, J. S. Gallagher, I. L. Bernstein, D. I. Bernstein. Antibodies to Morphine in Workers Occupationally Exposed to Opiates at a Narcotics Manufacturing Facility and Evidence for Similar Antibodies in Heroin Abusers, Life Sciences, 47, 897-908 (1990).
[26] Biagini, R. E., J. S. Gallagher, W. M. Moorman, E. A. Knecht, W. Smallwood, I. L. Bernstein, D. I. Bernstein. Immune Responses of Cynomlogus Monkeys to Phthalic Anhydride, Journal of Allergy and Clinical Immunology, 82, 23-29 (1988).
[27] Boeniger, M. F., L. K. Lowry, J. Rosenberg. Interpretation of Urine Results Used to Assess Chemical Exposure with Emphasis on Creatinine Adjustments: A Review, Am. Ind. Hyg. Assoc. J., 54, 615 (1993).
[28] Spencer, K. Analytical Reviews in Clinical Biochemistry: The Estimation of Creatinine, Ann. Clin. Biochem., 23, 1-25 (1986).
[29] Health Care Financing Administration and Public Health Service. 42 Code of Federal Regulations Part 493-Laboratory Requirements. Clinical Laboratory Improvement Amendments of 1988; Final Rule, in Federal Register, 57(40), 7137-7185 (February 28, 1992).
[30] International Commission on Occupational Health. International Code of Ethics for Occupational Health Professionals, Singapore (1992).
[31] Zielhuis, R. L. Biological Monitoring. Guest lecture given at the 26th Nordic Symposium on Industrial Hygiene, Helsinki, October 1977, Scand. J. Work, Environ. & Health, 4, 1 (1978).
[32] Bloodborne Pathogens, Catalog No. 858, Coastal Video Communications, Corp. Virginia Beach, Virginia (1992).
[33] Biosafety in Microbiological and Biomedical Laboratories, 3rd ed., J. Y. Richmond, R. W. McKinney, Eds., HHS Publication No. (CDC) 93-8395, Centers for Disease Control And Prevention and National Institutes of Health, U. S. Government Printing Office, Washington, D. C. (1993).
[34] American Conference of Governmental Industrial Hygienists (ACGIH). 1994-1995 Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices, 51-66, ACGIH, Cincinnati (1994).
[35] Deutsche Forschungsgemeinschaft (DFG). MAK- and BAT-Values 1992. Maximum Concentrations at the workplace and Biological Tolerance Values for Working Materials Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area. Report No. 28, 99-104, VCH Verlagsgesellschaft mbH, Weinheim (1992).
[36] Code of Federal Regulations, Title 29, Parts 1910.1025 Lead and 1910.1027 Cadmium, U.S. Government Printing Office, Washington, D. C.
[37] Murthy, L. I., W. E. Halperin. Medical Screening and Biological Monitoring. A Guide to the Literature for Physicians, Journal of Occupational and Environmental Medicine, 37(2), 170-184 (1995).
Manual of Analytical Methods
